No payment accepted from any clinic or pharmacy listed. No referral fees, no coupon codes, no partnerships.How we make money
← GLP Success
Comparison

Fridays vs Ivim Health

Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.

FridaysIvim Health
VerdictProfile in progressProfile in progress
Tirzepatide pricefrom $240/mo (12-mo prepay)from $548/mo (monthly plan)
Semaglutide pricefrom $150/mo (12-mo prepay)from $299/mo (monthly plan)
Pharmacy receiptNames its pharmacy (HealthWarehouse, Precision Medicine +2) — HealthWarehouse, Precision Medicine +2 state-verified by us in up to 16 states. Pick your state to check yours.Fills through Empower, Tailor Made per market data — Empower is an FDA-registered 503B outsourcing facility (federal cGMP oversight). Pick your state to check the rest.
Care receiptCare is outsourced to OpenLoop — a contract medical group named on the clinic's own site. The brand doesn't employ your clinician.In-house clinicians; check-ins and coaching on record.
Review integrityReview-integrity flag — 65% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold.Review-integrity flag — 66% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold.
Company addressLists a real-looking operating address on its own site.Lists a real-looking operating address on its own site.
PharmacyIn reviewIn review
Clinical supportIn reviewIn review
Patient supportIn reviewIn review
ValueIn reviewIn review
Ships toIn reviewIn review
Pharmacy modelFridays does not manufacture medication itself; per its own Terms, prescriptions are filled by named third-party U.S. 503A/503B compounding and dispensing pharmacy partners, with the specific fulfilling pharmacy varying by state and product.Telehealth platform that does not compound medication itself; a licensed provider evaluates the patient and prescribes compounded semaglutide or tirzepatide, which is then filled by external state-licensed compounding pharmacies. Ivim describes these as FDA-regulated, state-licensed compounding pharmacies and references Certificate of Analysis, sterility, potency, pH, and endotoxicity testing, but does not publicly name them. The FDA warning letter (02/20/2026) found that Ivim is not the compounder of the products despite product labels bearing the Ivim name.
Red flags on file11

Full profiles: Fridays · Ivim Health
State-aware license reads: the tirzepatide price board →